Subsidiary Predictive Laboratories hits milestone with 2,500 samples collected and processed since acquiring CLIA operations in March 2019; four new research sample collection initiatives set to begin ...
Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Feasibility of long-term patient reporting of toxicities from home via the internet during routine chemotherapy. The importance of early treatment to decrease therapy-related complications in Burkitt ...
The rules of digital engagement are changing rapidly, thanks to the rise of artificial intelligence and everything it brings to the table. One of the biggest shifts we're seeing in 2025 is happening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback